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ABSTRACT
Objective: To assess the presence of microorganism contamination in the preservation solution for 
transplant organs (kidney/pancreas). Method: Between August 2007 and March 2008, 136 samples 
of preservation solution were studied prior to graft implantation. Variables related to the donor and 
to the presence of microorganisms in the preservation solution of organs were evaluated, after which 
the contamination was evaluated in relation to the “recipient culture” variable. Univariate and mul-
tivariate statistical analyses were performed. Results: The contamination rate of the preservation 
solution was 27.9%. Coagulase-negative Staphylococcus was the most frequently isolated microor-
ganism. However, highly virulent agents, such as fungi and enterobacteria, were also isolated. In 
univariate analysis, the variable “donor antibiotic use” was significantly associated to the contami-
nation of the preservation solution. On the other hand, multivariate analysis found statistical sig-
nificance in “donor antibiotic use” and “donor’s infectious complications” variables. Conclusions: In 
this study, 27.9% of the preservation solutions of transplant organs were contaminated. Infectious 
diseases and non-use of antibiotics by the donor were significantly related to the presence of micro-
organisms in organ preservation solutions. Contamination in organ preservation solutions was not 
associated with infection in the recipient.
Keywords: organ transplantation; disease transmission, infectious; organ preservation solutions; mi-
crobial viability.
InTRoduCTIon
Every year, there is an increasing number of 
transplanted organs, and thus a need for great-
er organ availability. In the United States, the 
mortality rate for patients on the waiting list 
for an organ is around 7%.1 The disparity be-
tween organ supply and demand is translated 
by the use of high-risk donors for patients with 
advanced disease. 
It has been reported that 1.2-62% of in-
fectious agents, such as Gram-positive and 
Gram-negative bacteria, as well as fungi, are 
present in the preservation solution immedi-
ately after the collection process, suggesting 
that this stage is an important source of con-
tamination.2,3
The origin of contaminating microorgan-
isms is not always clear. There may be airborne 
transmission in the surgical environment 
from the surgical staff, surgical instruments or 
poor skin antisepsis.4 Concerning brain-dead 
donors, there is a higher risk of infection due 
to severe impairment of the cellular immune 
system, as well as hemodynamic instability, 
and subsequent bacterial translocation from 
the gut.5
MeThodS
This study aims to determine the presence of 
microbial infection in the preservation solution, 
prior to solid organ implantation (pancreas 
and kidney), by analyzing possible factors re-
lated to the risk of infection since these data 
were not found in Brazilian literature.
This study was conducted in the Kidney 
and Hypertension Hospital (São Paulo), during 
kidney and pancreas transplants from donors 
deceased in the period from August 2007 to 
March 2008.
One hundred thirty-six samples of organ 
preservation solution were prospectively ana-
lyzed for the presence of microorganisms prior 
to transplantation. Each sample of the preser-
vation solution came from an organ (kidney 
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or pancreas) collected from a total of 89 deceased donors. 
This study did not have an interventionist role. All organs 
were collected in accredited centers in São Paulo, which 
follow strict rules for excision, storage and transportation. 
Organs were preserved by using the static hypothermia tech-
nique with the organs still inside the donors’ bodies (in situ 
perfusion). After collection of the organs, they were placed 
in a sterile container (endo-bag), and immersed in preserva-
tion solution. They were kept at around 4°C. For each col-
lected organ, one of the following preservation solutions was 
used: Soltran®, Euro-Collins, Celsior® and Belzer. 
Samples of preservation solutions were collected from 
the container in which the organ was stored at the time of 
its removal from storage immediately prior to implantation. 
After homogenization of the solution, 10 mL was collected 
with a syringe and placed in a sterile universal collection bot-
tle. No quantitative analysis was performed with these sam-
ples, and the liquid was inoculated directly into a suitable 
medium, which was immediately transported to the hospital 
laboratory within a maximum interval of 2 hours between 
sample collection and inoculation into culture media.
Sheep Blood Agar, Sabouraud Agar and Brain-Heart-
Infusion (BHI) broth were used for sample processing.
After inoculation in the aforementioned culture media, 
the samples were incubated as described below:
- Blood Agar Medium and BHI broth at 35 ± 1°C for 72 
  hours, with daily readings.
- Sabouraud Agar medium at room temperature for 30 
 days, with periodic readings.
- Gram staining was performed on any growth obtained 
 in any culture media, and the isolated contaminating 
 agent was identified through biochemical tests specific 
 for each microorganism according to routine laboratory 
 protocol. Neither antimicrobial susceptibility test 
 (AST) nor microorganism genotyping were performed.
In order to assess the risk factors for the presence of 
microorganisms in the preservation solution, several vari-
ables related to the donor and the organ were evaluated. 
Among the variables related to the donor, age, duration 
of ICU stay, duration of antibiotic therapy, cause of death, 
gender, presence of infection and antibiotic use were con-
sidered. The variables associated with the transplanted 
organs were cold ischemia time, type of organ, and type 
of preservation solution. The presence of contamination in 
the preservation solution was then evaluated with the cul-
ture of the recipient variable.
All independent variables concerning donors and organs 
were compared to the dependent variable culture result of 
the preservation solution, by means of univariate analysis. 
The independent variable culture of the recipient was also 
compared to the culture result of the organ preservation so-
lution. Chi-square test and the Student’s t test were used for 
the evaluation of the categorical and quantitative variables, 
respectively. A p-value lower than 0.05 was considered sta-
tistically significant. A logistic regression model was fitted 
such that all independent variables were compared simul-
taneously with the dependent variable preservation solution 
culture. Statistical analyses were performed using the SPSS 
program version 10.0 (SPSS Statistical Software, Inc, 1999).6
The 136 samples of preservation solution for collected 
organs (kidney or pancreas) from 89 deceased donors 
were cultured. Of these, 50 donated a single kidney, 26 
donated two kidneys, five donated one kidney and a pan-
creas, and 8 donated two kidneys and a pancreas. In total, 
123 recipients benefited from these transplants, with 13 si-
multaneously receiving both a kidney and a pancreas.
Out of the 136 cultures of preservation solution, 38 
(27.9%) showed growth of some microorganism. The iso-
lated microorganisms are listed in Table 1.
In two recipients with active infectious processes and 
positive cultures, the same agent previously isolated in the 
culture of organ preservation solution was observed. In 
the first case, a urinary tract infection in the recipient caused 
by Enterococcus sp. was identified. This organism was isolat-
ed both in the urine culture of the kidney/pancreas recipient 
and in the culture of preservation solution. In the second 
case, an infection of the surgical site caused by Klebsiella 
pneumoniae was identified. This organism was isolated both 
in the culture of the surgical wound secretion of the recipi-
ent and in the culture of the preservation solution.
In the univariate analysis, the dependent variable culture 
of preservation solution was assessed against the other inde-
pendent variables. For statistical purposes, the total number of 
donors was considered to be 136, i.e., equal to the number 
of preservation solution samples (136 organs). Importantly, 
only three cultures from the same donor exhibited the same 
contaminant bacteria isolated from the organ preservation 
solutions. In this analysis only the categorical variable use of 
antibiotics by donor had a statistic significance (p = 0.0275). 
By analyzing all evaluated variables (risk factors) simul-
taneously, a significant of logistic regression model with the 
variables culture of preservation solution, use of antibiotics 
by donor (OR – 0.1956, CI (95%) – 0,0689, p – 0,0022) and 
infectious occurrences in donor (OR – 3.0495, CI (95%) – 
1.1725, p – 0,0222 ) was obtained. The other variables stud-
ied did not add significance to the model.
Using this logistic regression model, a probability matrix was 
obtained with all possible combinations of the predictor variable 
categories (infectious occurrences in donor and use of antibiotics 
by donor), where both predictor variables are dichotomous (yes/ 
no). In this matrix, there is a 70.1% chance of a positive preser-
vation solution culture in those cases where the donor had an 
infection and belonged to the group “not using antibiotics”.
Infection is still one of the main causes of morbidity 
and mortality after organ transplants, even with the use of 
modern antimicrobial agents.7 In solid organ transplants, 
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Table 1. Microorganisms isolated in the culture of 136 samples of solid organ preservation solution, prior to 
implantation of the graft
Culture of preservation solution Microorganisms Number of organs %
Without growth    98 72.46
  Gram-positive  
   Coagulase-negative Staphylococcus  11 7.97
   Bacillus spp. 5 3.62
   Enterococcus spp. 5 3.62
   Staphylococcus aureus 2 1.45
   Beta-hemolytic Streptococcus  1 0.72
  Gram-negative (monomicrobial)  
   Pseudomonas aeruginosa 2 1.45
   Acinetobacter spp. 2 1.45
   Acinetobacter baumannii 1 0.72
With growth  
   Acinetobacter iwoffii 1 0.72
   Escherichia coli 1 0.72
   Enterobacter spp. 1 0.72
   Klebsiella pneumoniae 1 0.72
  Fungi  
   Candida krusei 2 1.45
   Candida parapsilosis 1 0.72
   Candida parapsilosis / Escherichia coli 2 1.45 
   (polymicrobial)
Total    136 100.00
infectious processes are responsible for the majority of graft 
losses despite new immunosuppression protocols and efforts 
to identify infectious agents in both the donor and the re-
cipient.8-10 Prospective studies have reported mortality rates 
after transplants around 50% in the case of invasive fungal 
processes and up to 30% in the case of bacterial infections.11 
Up to 75% of transplanted patients will present some infec-
tious process in the first year after transplant.12
In Brazil, Linhares et al.13 demonstrated that in a series of 
45 combined pancreas/kidney transplants, 51% of infectious 
events required hospitalization, 71% of which were bacte-
rial, 16% viral and 13% fungal. Urinary and surgical wound 
infections were the most frequent infection foci. Infectious 
complications accounted for 50% mortality.
Today, there is a growing imbalance between supply 
and demand of organs. The use of non-ideal donors, such 
as those with documented infection, is becoming neces-
sary.10,14 Thus, the use of organs collected from donors with 
active bacterial and/or fungal infections, provided they are 
controllable, does not correlate to a significant increase in 
the number of complications in the recipient when routine 
antibiotic prophylaxis is administered.4,15 There are few re-
ports in the literature of the transmission of non-viral in-
fectious agents through the preservation solution during 
solid organ transplant with deceased donors. However, 
when present, these can be catastrophic. It is very difficult 
to differentiate the possible sources for the emergence of the 
infectious agent since its origin may be from the donor, 
exogenous (contamination), and/or reactivation of a la-
tent infection in the recipient.16
Preservation solutions may keep microorganisms viable, 
facilitate their growth, and even mediate an invasive infec-
tious process in an immunocompromised recipient.15 Con-
tamination of the preservation solution occurs frequently 
and is usually associated with the time of excision.4
The presence of contamination of the solution for organ 
preservation, at a rate of 27.9% as evidenced by this research, 
is comparable to data from other centers. 
In all four preservation solutions used in this study, the 
presence of microbial growth was observed. The vast major-
ity of the isolated agents observed were coagulase-negative 
Staphylococcus, reaching accounted for 29% of infections. 
When comparing this prevalence with that of other centers, 
it was observed that a large majority of isolated organisms 
Presence of microorganisms in preservation solution
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are also coagulase-negative Staphylococcus. These mi-
crobes are of low virulence and rarely cause a significant 
infectious process.4,8 The high incidence of these agents 
allows us to propose that their origin may be from breach 
of aseptic techniques during collection.4
However, there is a possibility of contamination of the 
preservation solution with organisms of high virulence 
and multidrug resistance. Among these are Staphylo-
coccus aureus, Pseudomonas spp., Klebsiella spp., Acine-
tobacter spp., Escherichia coli, Candida spp. and several 
others.4,5,17 All of the aforementioned agents were found 
in this study, totaling 71% of all microorganisms.
Cultures directed to anaerobic agents were not per-
formed in this research. Many of the reported studies in 
the literature do not perform routine screening for an-
aerobes. The limited information available suggests low 
levels of infection by these agents in the recipient.16
The concomitant presence of infectious complications 
in the donor and positive culture of the organ preser-
vation solution had a prevalence of 13.5% in this study. 
Univariate statistical analysis was not significant, but 
when the same variable was studied by the multivariate 
logistic regression model, it had statistical significance.
In a study conducted by Mattner et al.,18 involv-
ing lung, heart-lung, heart and liver transplants, there 
were no significant differences between incidence of 
post-transplant infections in patients from the group 
receiving contaminated organs versus the group that re-
ceived sterile organs.
Of the 89 deceased donors, 67 (75.3%) of them have 
used antibiotics during the ICU stay. Many of these 
antibiotics were used empirically based on laboratory 
findings and non-specific clinical signs with no major 
relevance. Only 17 (19.1%) donors who used antibiotics 
showed a growth in the culture of preservation solution. 
This finding showed statistical significance in its effec-
tiveness to inhibit microbial growth by using antibiotics 
both in univariate and in multivariate logistic regression 
analyses. Unfortunately, in this study it was not possible 
to correlate the contaminant agent of the preservation 
solution with the infectious agent in the donor because 
donors’ cultures were not routinely performed . 
Of the 123 recipients enrolled in this study, 42 
showed some infectious process, confirmed by culture 
performed up to the thirtieth day post-transplant.
Several studies have shown that the transmission of 
bacterial infections from the donor to the recipient is un-
common, ranging from 0 to 6.2%.19 Mattner et al.18 showed 
that 3.9% (11/282) of the recipients developed postopera-
tive infections with the same bacterial or fungal species that 
had grown in cultures of donor organs. Of these 11 species, 
six pairs were available for genotyping studies, and only one 
pair was proven to have the same genetic identity. Howev-
er, these authors did not demonstrate significant statistical 
association between contamination of the donated organ, 
infection and mortality.
In a study conducted by Cerutti et al.,5 mortality in the 
first year after transplant was significantly higher (5/11, 
45%) when transmission of infection from donor to recipi-
ent occurred than when it did not (49/547, 9%). In a study, 
Len et al.20 demonstrated that the transmission of infection 
from donor to recipient was documented in 5 of 292 patients 
(1.71%), 2 of whom did not survive the infection (40%). 
However, they found no difference in survival at 30 days 
among recipients who received organs from infected donors 
when compared to those who were not infected.
Coincidentally, it was noted that in two cases, the 
species of microorganism, isolated in cultures of 
the preservation medium was the same causing infec-
tions in the recipients. With respect to transmission of 
infection, objective evidence for the event can only be 
obtained by genotyping techniques, which would reveal 
the identity of microorganisms isolated in the donor and 
recipient. Unfortunately, such techniques are not widely 
available, and their application to microorganisms isolat-
ed in different laboratories is not feasible.5 In this study, 
the possible occurrence of transmission of the infectious 
agent from donor to recipient was only inferred when the 
same species was identified in both samples. Antimicro-
bial susceptibility could have also provided valuable in-
formation in this regard if it had been tested.
This study has limitations when attempting to relate 
causal factors for the presence of infection. Most of the 
data were collected in a previously established manner 
that, although performed according to a protocol, pre-
cludes collection of important data that could shed light 
on the incidence of contamination such as injury of the 
intestinal wall at the time of collection, duration of organ 
collection, contamination of surgical material or equip-
ment, and antiseptic technique used. The literature is 
clear when it refers to collection as the major source of 
contamination. There is no information of possible com-
plications during transport of the organ. 
The collection of samples for culture immediately af-
ter harvesting could be important to compare with the 
sample at the time of transplant. These data could provide 
additional information on other possible time points of 
contamination.
In addition, quantitative analysis of the presence of 
microorganisms in the preservation solution, along with 
the conduction of antibiogram, could yield valuable in-
formation on whether or not contamination occurred 
during the collection process. So far, it is not clear what is 
the best way to determine the presence of contamination 
of the donated organ and when it occurred.18 In this paper 
the lack of statistical significance comparing recipients 
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infection rates versus presence of contaminating micro-
organisms in the preservation solution may be explained 
by routine use of prophylactic antibiotics at the time of 
transplantation. Besides it should be taken into account 
the amount and virulence of contaminating microorgan-
isms in the preservation solution. 
Despite these limitations, this study provides impor-
tant information for groups working with solid organ 
transplants. There was a prevalence of 27.9% of contami-
nation by various agents in the liquid where the grafts 
were stored. Although most contamination was with 
agents of low virulence, microorganisms with high po-
tential for morbidity of the organ recipient were found.
According to this paper and medical review on the 
issue, care must be taken in patients presenting signs of 
infection, especially those which preservation solution 
cultures from the transplanted organ yielded virulent mi-
croorganisms like Staphylococcus aureus, Pseudomonas 
spp., Klebsiella spp., Acinetobacter spp. and so on. In these 
cases the potential risk of a severe infection must be con-
sidered and attention is required to prescribe the most 
suitable antibiotics, especially in immune suppressed pa-
tients.
The non-use of antibiotics and the presence of in-
fectious complications in the donor were significantly 
correlated with the presence of microorganisms in the 
preservation solution.
There is no connection between contamination of the 
solution for preserving organs and the presence of infec-
tious complications in the recipient.
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